Generative AI Adoption Soars, AI Drug Cleared, Medvi's $1.8B Success
Generative AI adoption is rapidly accelerating across industries, sparking a new wave of innovation. A major AI-designed drug candidate received IND clearance, while the FDA launched a pilot program for AI in clinical trials. Also, see how a two-person company leveraged AI to achieve $1.8B in revenue. Full edition: https://tech.pibrief.com/editions/2026-04-29
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.